Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
67.41
+2.24 (3.44%)
Oct 6, 2025, 3:11 PM EDT - Market open
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $2.85 billion as of October 6, 2025. Its market cap has increased by 129.81% in one year.
Market Cap
2.85B
Enterprise Value
2.56B
1-Year Change
129.81%
Ranking
Category
Stock Price
$67.41
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $2.85B, an increase of 823.48%. That is a compound annual growth rate of 56.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 2.75B | 29.98% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | 839.84M | 172.55% |
| Oct 16, 2020 | 308.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |